Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pregnancy and AIDS.

R Henrion1

  • 1Port-Royal University Clinic, Paris, France.

Human Reproduction (Oxford, England)
|February 1, 1988
PubMed
Summary

Identifying pregnant women at risk for HIV is crucial for early intervention. Approximately 40% of infants born to HIV-positive mothers may be contaminated, necessitating careful obstetric management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Is anonymous childbirth a sustainable option?].

La Revue du praticien·2011
Same author

[Report of the French Comité national technique de l'échographie de dépistage prénatal (prenatal ultrasound): what are the practical consequences?].

Gynecologie, obstetrique & fertilite·2006
Same author

[Domestic violence during pregnancy: screening and management].

Journal de gynecologie, obstetrique et biologie de la reproduction·2005
Same author

[Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].

Annales de medecine interne·2001
Same author

[At the Académie Nationale de Médecine. Prenatal screening of anti-HIV antibodies].

Presse medicale (Paris, France : 1983)·1997
Same author

Lack of behavioural risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women.

International journal of STD & AIDS·1997

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Pediatrics

Background:

  • Since the 1983 identification of pediatric Acquired Immunodeficiency Syndrome (AIDS), observations have increased.
  • Identifying pregnant women in high-risk groups is essential due to inconsistent HIV serology screening in Europe.
  • Risk groups include intravenous drug users, individuals from endemic regions, those with multiple sexual partners, co-infections, or partners with HIV.

Purpose of the Study:

  • To outline strategies for identifying and managing HIV-positive pregnant women.
  • To inform obstetricians about the risks of materno-fetal HIV transmission.
  • To guide obstetric management based on gestational stage and maternal/infant risk.

Main Methods:

  • Review of clinical observations and transmission data for HIV in pregnancy.
Keywords:
Acquired Immunodeficiency Syndrome--prevention and controlAge FactorsData AnalysisDemographic FactorsDeveloped CountriesDiseasesEuropeExaminations And DiagnosesFranceHigh Risk WomenHiv InfectionsInfantMediterranean CountriesPhysical Examinations And DiagnosesPopulationPopulation CharacteristicsPregnancyReproductionResearch MethodologySocial ProblemsSubstance AddictionViral DiseasesWestern EuropeYouth

Related Experiment Videos

  • Identification of maternal risk factors for HIV infection.
  • Assessment of materno-fetal transmission routes (transplacental, delivery, breastfeeding).

    • Main Results:

    • Materno-fetal HIV transmission is undebatable, occurring transplacentally, during delivery, or via breastfeeding.
    • Approximately 40% of infants born to HIV-positive mothers are contaminated.
    • Maternal HIV infection poses significant risks to the infant, with disease progression being rapid and severe.

    Conclusions:

    • HIV antibody testing is recommended at the start of pregnancy for women in identified risk groups.
    • Obstetric management varies by trimester: recommended abortion in the first, patient choice in the second, and natural delivery in the third.
    • Cesarean sections are reserved for standard obstetrical indications, not solely for HIV prevention.